Pharmaxis Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Pharmaxis Ltd.

Pharmaxis Ltd. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

BVF Partners LP

68,885,856

19.22%

5,062,187

1.07%

04/03/2018

Australian Ethical Investments Ltd. (Investment Management)

28,759,640

8.02%

-3,664,787

4.13%

04/03/2018

Allan Gray Australia Pty Ltd.

20,578,767

5.74%

-1,806,631

0.16%

08/14/2018

Schröder Equities GmbH

1,428,281

0.4%

2.34%

06/29/2018

View Profile

Address	20 Rodborough Road Sydney New South Wales (NSW) 2086 Australia
Employees	-
Website	http://www.pharmaxis.com.au
Updated	07/08/2019
Pharmaxis Ltd. operates as a specialty pharmaceutical company, which engages in the development and commercialization of therapeutic products for chronic respiratory disorders, autoimmune diseases, and improved lung function test. It operates through the following segments: Bronchitol and Aridol Business and New Drug Development. The Bronchitol and Aridol Business segment covers the ongoing clinical development, manufacture, and sale of the Bronchitol and Aridol globally.